Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) CEO James Lanthier joins Proactive's Stephen Gunnion with details of an exclusive licensing agreement for Cybin Inc to acquire intellectual property rights for a subset of Mindset's preclinical compounds.
Lanthier noting that this is Mindset's second such agreement to advance its innovations to clinical study, giving the company multiple 'shots for the goal'.
#ProactiveInvestors #MindsetPharma #Cybin #CSE #OTCQB